CFO Todd Thomson Sells 280,000 Actuate Shares in Routine Liquidity Move Amidst Quiet Market Reaction
Actuate Therapeutics insider sale: CFO Todd Thomson’s 280,000‑share sell‑off is a routine liquidity move, not a warning. Focus on upcoming pancreatic data and partnership news for upside.
3 minutes to read